The Gross Margin of Neurocrine Biosciences Inc (NBIX) is 98.56%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 98.56% |
| 2023-12-31 | 97.90% |
| 2022-12-31 | 98.44% |
| 2021-12-31 | 98.74% |
| 2020-12-31 | 99.03% |
| 2019-12-31 | 99.06% |
| 2018-12-31 | 98.94% |
| 2017-12-31 | 99.26% |